Table 2. Incidence Rates of AIDS-Defining Opportunistic Infections during ART.
| AIDS-defining illnesses (ADIs) | Number of episodes, Incidence Rate (/1000 PYS), (95%CI) | |||||
|---|---|---|---|---|---|---|
| All (n = 1,197; 3,446 person-years) | No prior ADIs at baseline (n = 951; 2,763 person-years) | |||||
| Any ADIs | 161 | 46.7 | (39.8–54.5) | 130 | 47.1 | (39.3–55.9) |
| Tuberculosis | 98 | 28.4 | (23.1–34.7) | 79 | 28.6 | (22.6–35.6) |
| Toxoplasmosis of brain | 16 | 4.64 | (2.65–7.54) | 14 | 5.01 | (2.77–8.50) |
| Pneumocystis pneumonia | 10 | 2.90 | (1.39–5.34) | 8 | 2.89 | (1.25–5.70) |
| Esophageal candidiasis | 7 | 2.03 | (0.82–4.19) | 7 | 2.53 | (1.02–5.22) |
| Cytomegalovirus retinitis | 6 | 1.74 | (0.64–3.79) | 6 | 2.17 | (0.80–4.72) |
| Mycobacterium avium complex | 6 | 1.74 | (0.64–3.79) | 4 | 1.45 | (0.39–3.71) |
| Recurrent bacterial pneumonia | 5 | 1.45 | (0.47–3.39) | 4 | 1.45 | (0.39–3.71) |
| Cryptococcus | 4 | 1.16 | (0.32–2.97) | 4 | 1.45 | (0.39–3.71) |
| Cervical cancer | 2 | 0.58 | (0.070–2.10) | 2 | 0.72 | (0.088–2.61) |
| Progressive multifocal leukoencephalopathy | 2 | 0.58 | (0.070–2.10) | 0 | - | - |
| Disseminated HSV infection | 2 | 0.58 | (0.070–2.10) | 0 | - | - |
| Primary CNS lymphoma | 1 | 0.29 | (0.007–1.62) | 0 | - | - |
| Non-Hodgkin’s lymphoma | 1 | 0.29 | (0.007–1.62) | 1 | 0.36 | (0.009–2.01) |
| Salmonella septicemia | 1 | 0.29 | (0.007–1.62) | 1 | 0.36 | (0.009–2.01) |
CNS: central nervous system